Compliance with doxycycline therapy in sexually transmitted diseases clinics

Clicks: 420
ID: 119669
1998
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #10 of 18 articles by views in Sexually Transmitted Diseases

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Few patients administered doxycycline in an STD clinic can be expected to take medication precisely as prescribed. Although most probably take enough to eradicate uncomplicated chlamydial infections, a sizable portion can be expected to use an inadequate amount of medication. This may contribute to …
Reference Key
m1998sexuallycompliance Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Augenbraun M, Bachmann L, Wallace T, Dubouchet L, McCormack W, Hook EW
Are you one of these authors? Claim your profile
Journal Sexually Transmitted Diseases
Year 1998
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/9437776
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't adult female male anti-bacterial agents / therapeutic use* e w hook patient compliance* chlamydia infections / drug therapy* doxycycline / therapeutic use* chlamydia trachomatis* pmid:9437776 doi:10.1097/00007435-199801000-00001 m augenbraun l bachmann

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.